Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study
Authors:
- 1 January 1999
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 53 (1) , 51-59
Abstract
Aim: To quantify the changes in biological molecular markers during primary medical treatment in patients with operable breast cancer and to assess their possible relationship with response to...Keywords
This publication has 23 references indexed in Scilit:
- Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifenBritish Journal of Cancer, 1994
- The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinomaBritish Journal of Cancer, 1994
- Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor statusBritish Journal of Cancer, 1993
- DNA flow cytometry and response to preoperative chemotherapy for primary breast cancerEuropean Journal of Cancer, 1992
- Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporationBritish Journal of Cancer, 1991
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI: Journal of the National Cancer Institute, 1990
- Immunocytochemical Analysis of Estrogen Receptors in Human Breast CarcinomasArchives of Surgery, 1990
- Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancerBritish Journal of Cancer, 1989
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977